|
Volumn 104, Issue 2, 2011, Pages 611-
|
The role of 99mTc-tetrofosmin brain SPECT in differentiating treatment-induced necrosis from recurrent brain tumor
|
Author keywords
[No Author keywords available]
|
Indexed keywords
METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;
TETROFOSMIN TC 99M;
ANTINEOPLASTIC AGENT;
DIAGNOSTIC AGENT;
ORGANOPHOSPHORUS COMPOUND;
RADIOPHARMACEUTICAL AGENT;
TECHNETIUM COMPLEX;
BRAIN HEMORRHAGE;
BRAIN NECROSIS;
BRAIN TUMOR;
DIFFERENTIAL DIAGNOSIS;
DIFFUSION WEIGHTED IMAGING;
GLIOMA;
HUMAN;
INTERMETHOD COMPARISON;
LETTER;
MOLECULAR IMAGING;
MULTIDRUG RESISTANCE;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
PERFUSION WEIGHTED IMAGING;
PHENOTYPE;
POSITRON EMISSION TOMOGRAPHY;
RADIATION NECROSIS;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
TUMOR RECURRENCE;
BRAIN DISEASE;
FEMALE;
MALE;
METHODOLOGY;
NECROSIS;
NOTE;
RADIATION INJURY;
SCINTISCANNING;
ANTINEOPLASTIC AGENTS;
BRAIN DISEASES;
BRAIN NEOPLASMS;
FEMALE;
HUMANS;
MALE;
NECROSIS;
NEOPLASM RECURRENCE, LOCAL;
ORGANOPHOSPHORUS COMPOUNDS;
ORGANOTECHNETIUM COMPOUNDS;
RADIATION INJURIES;
RADIOPHARMACEUTICALS;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
|
EID: 80052623502
PISSN: 0167594X
EISSN: 15737373
Source Type: Journal
DOI: 10.1007/s11060-010-0507-z Document Type: Letter |
Times cited : (1)
|
References (4)
|